Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
UVIC's Cash to Debt is ranked lower than
98% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. UVIC: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
UVIC' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.10 Max: No Debt
Current: 0.02
Equity to Asset -0.61
UVIC's Equity to Asset is ranked lower than
96% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. UVIC: -0.61 )
Ranked among companies with meaningful Equity to Asset only.
UVIC' s 10-Year Equity to Asset Range
Min: -2.38  Med: -0.52 Max: 0.91
Current: -0.61
-2.38
0.91
Interest Coverage 8.23
UVIC's Interest Coverage is ranked lower than
79% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. UVIC: 8.23 )
Ranked among companies with meaningful Interest Coverage only.
UVIC' s 10-Year Interest Coverage Range
Min: 0.47  Med: 10.45 Max: 9999.99
Current: 8.23
0.47
9999.99
F-Score: 8
Z-Score: -1.57
M-Score: -2.73
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 19.64
UVIC's Operating margin (%) is ranked higher than
85% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. UVIC: 19.64 )
Ranked among companies with meaningful Operating margin (%) only.
UVIC' s 10-Year Operating margin (%) Range
Min: -12.22  Med: 1.36 Max: 31.86
Current: 19.64
-12.22
31.86
Net-margin (%) 11.71
UVIC's Net-margin (%) is ranked higher than
76% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.95 vs. UVIC: 11.71 )
Ranked among companies with meaningful Net-margin (%) only.
UVIC' s 10-Year Net-margin (%) Range
Min: -20.03  Med: 14.98 Max: 149.13
Current: 11.71
-20.03
149.13
ROA (%) 25.94
UVIC's ROA (%) is ranked higher than
96% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. UVIC: 25.94 )
Ranked among companies with meaningful ROA (%) only.
UVIC' s 10-Year ROA (%) Range
Min: -28.96  Med: 22.08 Max: 126.95
Current: 25.94
-28.96
126.95
ROC (Joel Greenblatt) (%) 85.32
UVIC's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. UVIC: 85.32 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UVIC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -143.16  Med: 41.33 Max: 127.53
Current: 85.32
-143.16
127.53
Revenue Growth (3Y)(%) 5.50
UVIC's Revenue Growth (3Y)(%) is ranked higher than
53% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. UVIC: 5.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UVIC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -4.8  Med: 9.20 Max: 36.5
Current: 5.5
-4.8
36.5
EBITDA Growth (3Y)(%) -5.30
UVIC's EBITDA Growth (3Y)(%) is ranked lower than
75% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. UVIC: -5.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UVIC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -50.4  Med: 8.70 Max: 181.9
Current: -5.3
-50.4
181.9
EPS Growth (3Y)(%) -7.40
UVIC's EPS Growth (3Y)(%) is ranked lower than
74% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. UVIC: -7.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UVIC' s 10-Year EPS Growth (3Y)(%) Range
Min: -38.3  Med: -7.00 Max: 20.5
Current: -7.4
-38.3
20.5
» UVIC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with UVIC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.70
UVIC's P/E(ttm) is ranked higher than
79% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.10 vs. UVIC: 17.70 )
Ranked among companies with meaningful P/E(ttm) only.
UVIC' s 10-Year P/E(ttm) Range
Min: 0.91  Med: 9.01 Max: 17.66
Current: 17.7
0.91
17.66
PE(NRI) 17.50
UVIC's PE(NRI) is ranked higher than
80% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.00 vs. UVIC: 17.50 )
Ranked among companies with meaningful PE(NRI) only.
UVIC' s 10-Year PE(NRI) Range
Min: 0.9  Med: 8.99 Max: 17.54
Current: 17.5
0.9
17.54
P/S 2.08
UVIC's P/S is ranked higher than
62% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. UVIC: 2.08 )
Ranked among companies with meaningful P/S only.
UVIC' s 10-Year P/S Range
Min: 0.75  Med: 1.69 Max: 3.88
Current: 2.08
0.75
3.88
PFCF 20.70
UVIC's PFCF is ranked higher than
78% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.24 vs. UVIC: 20.70 )
Ranked among companies with meaningful PFCF only.
UVIC' s 10-Year PFCF Range
Min: 4.12  Med: 7.73 Max: 20.7
Current: 20.7
4.12
20.7
POCF 14.38
UVIC's POCF is ranked higher than
71% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.89 vs. UVIC: 14.38 )
Ranked among companies with meaningful POCF only.
UVIC' s 10-Year POCF Range
Min: 3.61  Med: 7.13 Max: 14.56
Current: 14.38
3.61
14.56
EV-to-EBIT 13.05
UVIC's EV-to-EBIT is ranked higher than
78% of the 116 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.04 vs. UVIC: 13.05 )
Ranked among companies with meaningful EV-to-EBIT only.
UVIC' s 10-Year EV-to-EBIT Range
Min: -3175.3  Med: 10.10 Max: 2313
Current: 13.05
-3175.3
2313
PEG 7.00
UVIC's PEG is ranked lower than
81% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. UVIC: 7.00 )
Ranked among companies with meaningful PEG only.
UVIC' s 10-Year PEG Range
Min: 0.05  Med: 0.14 Max: 16.67
Current: 7
0.05
16.67
Shiller P/E 19.82
UVIC's Shiller P/E is ranked higher than
76% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.41 vs. UVIC: 19.82 )
Ranked among companies with meaningful Shiller P/E only.
UVIC' s 10-Year Shiller P/E Range
Min: 4.12  Med: 7.78 Max: 19.9
Current: 19.82
4.12
19.9
Current Ratio 1.12
UVIC's Current Ratio is ranked lower than
91% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.56 vs. UVIC: 1.12 )
Ranked among companies with meaningful Current Ratio only.
UVIC' s 10-Year Current Ratio Range
Min: 0.3  Med: 1.46 Max: 7.71
Current: 1.12
0.3
7.71
Quick Ratio 0.80
UVIC's Quick Ratio is ranked lower than
85% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. UVIC: 0.80 )
Ranked among companies with meaningful Quick Ratio only.
UVIC' s 10-Year Quick Ratio Range
Min: 0.13  Med: 1.12 Max: 6.2
Current: 0.8
0.13
6.2
Days Inventory 65.64
UVIC's Days Inventory is ranked higher than
84% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 125.77 vs. UVIC: 65.64 )
Ranked among companies with meaningful Days Inventory only.
UVIC' s 10-Year Days Inventory Range
Min: 60.67  Med: 85.00 Max: 111.2
Current: 65.64
60.67
111.2
Days Sales Outstanding 31.24
UVIC's Days Sales Outstanding is ranked higher than
90% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.15 vs. UVIC: 31.24 )
Ranked among companies with meaningful Days Sales Outstanding only.
UVIC' s 10-Year Days Sales Outstanding Range
Min: 32.13  Med: 49.95 Max: 66.12
Current: 31.24
32.13
66.12

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.74
UVIC's Dividend Yield is ranked higher than
96% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. UVIC: 1.74 )
Ranked among companies with meaningful Dividend Yield only.
UVIC' s 10-Year Dividend Yield Range
Min: 1.32  Med: 7.10 Max: 13.24
Current: 1.74
1.32
13.24
Dividend Payout 0.31
UVIC's Dividend Payout is ranked higher than
55% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. UVIC: 0.31 )
Ranked among companies with meaningful Dividend Payout only.
UVIC' s 10-Year Dividend Payout Range
Min: 0.21  Med: 0.69 Max: 1.5
Current: 0.31
0.21
1.5
Dividend growth (3y) -17.00
UVIC's Dividend growth (3y) is ranked lower than
77% of the 56 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. UVIC: -17.00 )
Ranked among companies with meaningful Dividend growth (3y) only.
UVIC' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 17
Current: -17
0
17
Yield on cost (5-Year) 0.52
UVIC's Yield on cost (5-Year) is ranked higher than
51% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.52 vs. UVIC: 0.52 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
UVIC' s 10-Year Yield on cost (5-Year) Range
Min: 0.39  Med: 2.12 Max: 3.95
Current: 0.52
0.39
3.95
Share Buyback Rate 6.70
UVIC's Share Buyback Rate is ranked higher than
96% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.10 vs. UVIC: 6.70 )
Ranked among companies with meaningful Share Buyback Rate only.
UVIC' s 10-Year Share Buyback Rate Range
Min: 19.6  Med: 0.10 Max: -5.6
Current: 6.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.49
UVIC's Price/Projected FCF is ranked higher than
63% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. UVIC: 1.49 )
Ranked among companies with meaningful Price/Projected FCF only.
UVIC' s 10-Year Price/Projected FCF Range
Min: 0.23  Med: 0.68 Max: 3.58
Current: 1.49
0.23
3.58
Price/Median PS Value 1.23
UVIC's Price/Median PS Value is ranked higher than
51% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.24 vs. UVIC: 1.23 )
Ranked among companies with meaningful Price/Median PS Value only.
UVIC' s 10-Year Price/Median PS Value Range
Min: 0.01  Med: 0.84 Max: 2.07
Current: 1.23
0.01
2.07
Earnings Yield (Greenblatt) (%) 7.70
UVIC's Earnings Yield (Greenblatt) (%) is ranked higher than
85% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. UVIC: 7.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UVIC' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.1  Med: 9.60 Max: 31.7
Current: 7.7
0.1
31.7
Forward Rate of Return (Yacktman) (%) 3.67
UVIC's Forward Rate of Return (Yacktman) (%) is ranked lower than
68% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.68 vs. UVIC: 3.67 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
UVIC' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -24.4  Med: 3.70 Max: 106.1
Current: 3.67
-24.4
106.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:UVI.Canada,
Unilens Vision, Inc. was incorporated in 1989, to the State of Delaware on April 1, 2010. The company licenses, manufacture, distribute and market specialty optical lens products using proprietary design and manufacturing technology. Its products are sold primarily in the United States solely to eye care professionals through in house sales representatives, independent sales brokers and a network of distributors. Its lens products are marketed as a family of specialty vision correction products that can serve the majority of the population's vision correction needs. Its specialty optical lens business is divided into four categories: (i) disposable lenses; (ii) custom soft lenses; (iii) gas permeable lenses; and (iv) replacement and other lenses. Its disposable lenses line consists of the C-Vue, a mulitfocal cast molded blister-packed box of six lenses sold for frequent replacement, the C-Vue Aspheric single vision lens, a single vision disposable soft contact lens sold for 2-week replacement and the C-Vue 1 Day Aspheric single vision daily disposable soft contact lens sold for one day wear then just simply thrown away. The C-Vue multifocal lens is manufactured for it by a third party utilizing one of its patented soft lens designs and is marketed exclusively in the United States to eye care professionals. The cast molded C-Vue Aspheric single vision lens and the C-Vue 1 Day Aspheric single vision lens are each manufactured for it by a third party utilizing Wavefront inspired technology. The company markets the C-Vue Aspheric single vision lens in a blister-packed box of six lenses and the C-Vue 1 Day Aspheric single vision lens in blister-packs of 30 and 90 lenses. Its custom soft lenses line of soft lathe-cut products includes the C-Vue Toric Multifocal, designed for patients with an astigmatism that require bifocal correction, the C-Vue Custom Toric and the C-Vue 55 multifocal, a high-add multifocal, manufactured in a comfortable high-water content material, all available in its Advanced line of biocompatible materials. Its gas permeable lens line of products consist of the Unilens GP, a multifocal contact lens intended for patients with astigmatism who need low to moderate presbyopic correction; the Unilens GP Plus, designed to accommodate wearers requiring presbyopic correction; the C-Vue GP, a front aspheric design incorporating the C-Vue design technology and the C-Ray GP utilizing its recently patented design technology, featuring an on eye ray traced power profile over an elliptical base. Its replacement and other lenses line of products primarily consists of the Unilens, an aspheric multifocal contact lens; the SoftSite, a highadd multifocal contact lens; the SimulVue, a simultaneous vision bifocal contact lens with the capabilities for correcting advanced presbyopia; the Unilens EMA, a visibility tinted multifocal contact lens available in planned replacement modality; the LifeStyle brand of toric multifocal, toric and
» More Articles for UVIC

Headlines

Articles On GuruFocus.com
Unilens Vision to Present at LD MICRO "Main Event" Micro-Cap Growth Conference on Wednesday, Decembe Nov 20 2014 
comment on UVIC Nov 15 2012 

More From Other Websites
Unilens Vision Inc. Named to 2015 OTCQX Best 50 May 18 2015
Unilens Vision Inc. Named to 2015 OTCQX Best 50 May 18 2015
10-Q for Unilens Vision, Inc. May 17 2015
Unilens Vision Reports Third Quarter Operating Results May 14 2015
Unilens Vision Reports Third Quarter Operating Results May 14 2015
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share May 01 2015
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share May 01 2015
Unilens Vision Reports Higher Sales, Royalty Income, and Earnings for Second Quarter of FY2015 Feb 12 2015
Unilens Vision Reports Higher Sales, Royalty Income, and Earnings for Second Quarter of FY2015 Feb 12 2015
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share Feb 02 2015
UNILENS VISION INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Dec 17 2014
Unilens Vision to Present at LD MICRO "Main Event" Micro-Cap Growth Conference on Wednesday,... Nov 24 2014
UNILENS VISION INC Financials Nov 21 2014
Unilens Vision to Present at LD MICRO "Main Event" Micro-Cap Growth Conference on Wednesday,... Nov 20 2014
UNILENS VISION INC Files SEC form 10-Q, Quarterly Report Nov 14 2014
Unilens Vision Reports First Quarter FY2015 Operating Results Nov 13 2014
Unilens Vision Reports First Quarter FY2015 Operating Results Nov 13 2014
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share Nov 03 2014
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share Nov 03 2014
UNILENS VISION INC Files SEC form 10-K, Annual Report Sep 29 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK